ly3372689
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 5, 2019 (NCT03819270)
Timeline
Indications
Mechanism of action
- Bifunctional protein NCOATINHIBITOR
OGA inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05749848 | Phase 1 | Feb 24, 2023 | Eli Lilly |
| NCT05063539 | Phase 2 | Sep 16, 2021 | Eli Lilly |
| NCT04392271 | Phase 1 | Aug 9, 2020 | Eli Lilly |
| NCT04106206 | Phase 1 | Oct 23, 2019 | Eli Lilly |
| NCT03944031 | Phase 1 | May 8, 2019 | Eli Lilly |
| NCT03819270 | Phase 1 | Feb 5, 2019 | Eli Lilly |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 6 | 6 | 2 | 2019 |
1 organizations
Page 1 / 1